Stocktoria

COMPASS Pathways plc CMPS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-09-18 · LEI

COMPASS Pathways plc statistics & valuation

Market cap$1.8B
Net cash$118.0M
Enterprise value USD$1.7B
Earnings yield EBIT/EV-10.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-30.70% -25.20% -50.50% -52.50% -100.30% 2019202020212022202320242025
Shares outstanding
7.5M 35.9M 40.0M 42.4M 61.9M 68.6M 96.1M 2019202020212022202320242025
Net debt ($)
-$143.2M -$191.4M -$134.9M -$118.0M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-60.60% -29.70% -23.80% -46.40% -42.90% -72.60% -136.80% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
0.00× 0.13× 0.19× 2019202020212022202320242025
EPS ($)
-$2.62 -$3.55 -$1.79 -$2.16 -$2.32 -$2.30 -$3.08 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-136.8%-72.6%-42.9%-46.4%-23.8%-29.7%-60.6%
Return on equity544.7%-100.3%-52.5%-50.5%-25.2%-30.7%64.5%
Debt / equity-0.60×0.19×0.13×0.00×———
Current ratio0.775.9213.3312.2919.5529.361.35

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.